These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7046953)

  • 1. Macrophages migration inhibition by complement activators, migration inhibitory factor, and Lotus fucolectin: evidence for common involvement of cell-associated esterase activity.
    Leu RW; Herriott MJ
    Cell Immunol; 1982 Apr; 68(2):302-10. PubMed ID: 7046953
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased Fc and C3 receptor function in macrophage populations which are refractory to migration inhibitory factor, C3 activators, and immune complex.
    Leu RW; Hefley SM; Herriott MJ
    Cell Immunol; 1983 Aug; 80(1):31-42. PubMed ID: 6347401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities in enhanced glucosamine incorporation by macrophages stimulated with migration inhibitory factor and the fucolectin from Lotus tetragonolobus.
    Leu RW; Brewer MA; Huddleston DJ
    Cell Immunol; 1980 Sep; 55(1):227-35. PubMed ID: 7000375
    [No Abstract]   [Full Text] [Related]  

  • 4. Lotus tetragonolobus fucolectin as a potential model for "MIF-like" modulation of macrophage function: comparison of the interaction of Lotus fucose binding protein (FBP) and migration inhibitory factor (MIF) with macrophages in the migration inhibition assay.
    Leu RW; Whitley SB; Herriott J; Huddleston DJ
    Cell Immunol; 1980 Jul; 52(2):414-28. PubMed ID: 7002321
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and macrophage-migration inhibition.
    Fox RA; Rajaraman K
    Cell Immunol; 1980 Aug; 53(2):333-40. PubMed ID: 6250727
    [No Abstract]   [Full Text] [Related]  

  • 7. Different effect of (L)-fucose binding lectin on macrophage migration inhibition caused by guinea pig migration inhibitory factor and synthetic muramyl dipeptide.
    Homma Y; Onozaki K; Hashimoto T; Miura K; Nagao S; Tanaka A
    Int Arch Allergy Appl Immunol; 1981; 65(1):27-33. PubMed ID: 7012040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of fluoresceinated Lotus tetragonolobus fucolectin to macrophage populations which are either responsive or refractory to activation by lymphokine.
    Leu RW; Herriott MJ; Webb CF
    Immunobiology; 1985 Apr; 169(3):272-9. PubMed ID: 3888826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of cell surface changes of guinea pig macrophages activated with purified migration inhibitory factor/macrophage activation factor.
    Homma Y; Onozaki K; Fukutomi Y; Hashimoto T
    Cell Immunol; 1982 Sep; 72(2):231-8. PubMed ID: 6185234
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines.
    Nagao S; Tanaka A; Onozaki K; Hashimoto T
    Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096
    [No Abstract]   [Full Text] [Related]  

  • 12. [Macrophage migration inhibition factor].
    Medunitsyn NV
    Usp Sovrem Biol; 1977; 84(5):248-56. PubMed ID: 352001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Macrophage migration inhibition factor].
    Medunitsyn NV
    Usp Sovrem Biol; 1977; 84(2):248-56. PubMed ID: 341567
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of MIF and the role of macrophage associated esterases in the response of the macrophage to MIF.
    Remold HG; Mednis AD; McCarthy PL
    Adv Exp Med Biol; 1979; 114():465-8. PubMed ID: 380297
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage activation induced by lymphocyte mediators.
    David JR
    Acta Endocrinol Suppl (Copenh); 1975; 194():245-61. PubMed ID: 1092116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
    Gordon MR; Chida K; Takata I; Myrvik QN
    J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of macrophage activation induced by Ca2+ ionophore.
    Onozaki K; Takenawa T; Homma Y; Hashimoto T
    Cell Immunol; 1983 Feb; 75(2):242-54. PubMed ID: 6403251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.
    Wu J; Cunha FQ; Liew FY; Weiser WY
    J Immunol; 1993 Oct; 151(8):4325-32. PubMed ID: 7691945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.